Literature DB >> 8517507

Aminoglycoside volume of distribution and illness severity in critically ill septic patients.

P E Marik1.   

Abstract

The volume of distribution of amikacin and the APACHE II score were determined in 42 critically ill patients being treated for a gram-negative infection. The mean volume of distribution (Vdt) was 0.41 +/- 0.12 l/kg with a wide range (normal of 0.25 l/kg). There was a good relationship between the Vdt and illness severity as measured by the APACHE II score (r = 0.70; P < 0.001). Critically ill patients should receive larger loading doses of aminoglycosides in order to achieve therapeutic blood levels. The aminoglycoside Vdt may be useful in determining the degree of capillary leak and tissue oedema that accompanies sepsis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8517507     DOI: 10.1177/0310057X9302100206

Source DB:  PubMed          Journal:  Anaesth Intensive Care        ISSN: 0310-057X            Impact factor:   1.669


  36 in total

1.  Using population pharmacokinetics to determine gentamicin dosing during extended daily diafiltration in critically ill patients with acute kidney injury.

Authors:  Jason A Roberts; Jonathan Field; Adam Visser; Rosemary Whitbread; Mandy Tallot; Jeffrey Lipman; Carl M J Kirkpatrick
Journal:  Antimicrob Agents Chemother       Date:  2010-06-14       Impact factor: 5.191

2.  Therapeutic drug monitoring of antimicrobials.

Authors:  Jason A Roberts; Ross Norris; David L Paterson; Jennifer H Martin
Journal:  Br J Clin Pharmacol       Date:  2012-01       Impact factor: 4.335

3.  Serum levels of daptomycin in pediatric patients.

Authors:  C Antachopoulos; E Iosifidis; K Sarafidis; F Bazoti; E Gikas; A Katragkou; V Drossou-Agakidou; E Roilides
Journal:  Infection       Date:  2012-01-21       Impact factor: 3.553

Review 4.  Clinical implications of antibiotic pharmacokinetic principles in the critically ill.

Authors:  Andrew A Udy; Jason A Roberts; Jeffrey Lipman
Journal:  Intensive Care Med       Date:  2013-09-18       Impact factor: 17.440

5.  Influence of experimental rat model of multiple organ dysfunction on cefepime and amikacin pharmacokinetics.

Authors:  O Mimoz; A Jacolot; C Padoin; J Quillard; M Tod; K Louchahi; K Samii; O Petitjean
Journal:  Antimicrob Agents Chemother       Date:  1996-03       Impact factor: 5.191

Review 6.  Pharmacokinetic and pharmacodynamic considerations when treating patients with sepsis and septic shock.

Authors:  Peter De Paepe; Frans M Belpaire; Walter A Buylaert
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

7.  Gentamicin in hemodialyzed critical care patients: early dialysis after administration of a high dose should be considered.

Authors:  Anne Veinstein; Nicolas Venisse; Julie Badin; Michel Pinsard; René Robert; Antoine Dupuis
Journal:  Antimicrob Agents Chemother       Date:  2012-12-10       Impact factor: 5.191

Review 8.  [Therapeutic drug monitoring and individual dosing of antibiotics during sepsis : Modern or just "trendy"?]

Authors:  A Brinkmann; A C Röhr; A Köberer; T Fuchs; J Preisenberger; W A Krüger; O R Frey
Journal:  Med Klin Intensivmed Notfmed       Date:  2016-09-13       Impact factor: 0.840

9.  Population pharmacokinetic study of isepamicin with intensive care unit patients.

Authors:  M Tod; C Padoin; C Minozzi; J Cougnard; O Petitjean
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

10.  Revisiting the loading dose of amikacin for patients with severe sepsis and septic shock.

Authors:  Fabio Silvio Taccone; Pierre-François Laterre; Herbert Spapen; Thierry Dugernier; Isabelle Delattre; Brice Layeux; Daniel De Backer; Xavier Wittebole; Pierre Wallemacq; Jean-Louis Vincent; Frédérique Jacobs
Journal:  Crit Care       Date:  2010-04-06       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.